Trump’s Covid Views Don’t Track With Reality That Recent Studies Suggest
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
Public Health
with
61 - 80 of 3,650 Results
-
-
This Teen Never Got His Day in Vaccine Court. His Former Lawyer Now Advises RFK on Its Overhaul.
The federal government’s Vaccine Injury Compensation Program was supposed to help patients with their medical bills while protecting vaccine supply. But allies of Health and Human Services Secretary Robert F. Kennedy Jr. are routinely transferring cases from that program to launch lawsuits against drugmakers.
-
Trump Policies at Odds With Emerging Understanding of Covid’s Long-Term Harm
Studies increasingly offer insights into the health risks and burdens faced by people who have had covid infections. Meanwhile, the Trump administration has narrowed covid vaccine recommendations and cut research.
Health Spending Is Moving in Congress
Episode 430Lawmakers appear on the brink of passing a spending bill for the Department of Health and Human Services and a bipartisan health policy bill delayed for over a year. But the outlook is bleaker for the health care outline released by President Trump last week. Sandhya Raman of CQ Roll Call, Sheryl Gay Stolberg of The New York Times, and Paige Winfield Cunningham of The Washington Post join KFF Health News’ Julie Rovner to discuss those stories and more. Also this week, Rovner interviews oncologist and bioethicist Ezekiel Emanuel to discuss his new book, “Eat Your Ice Cream.”
-
As US Is Poised To Lose Measles-Free Status, RFK Jr.’s New CDC Deputy Downplays Its Significance
Measles is at a 30-year high in the U.S., but technicalities may stave off the loss of the nation’s measles elimination status.
By Amy Maxmen -
Medicaid Tries New Approach With Sickle Cell: Companies Get Paid Only if Costly Gene Therapies Work
The government is using sickle cell treatments to test a new strategy: paying only if the therapies benefit patients. With more expensive treatments on the horizon, the program — created by the Biden administration and continued under President Trump — could help Medicaid save money and treat more patients.
-
Physician-Journalist Shines Light on Measles Upsurge and New GLP-1 Study
KFF Health News' editor-at-large for public health recently took to the airwaves to discuss topical stories. Here’s a collection of her appearances.
-
How Is Your County Spending Opioid Settlement Cash? Our New Tool Follows the Money.
Lifesaving or wasteful? Opinion is divided on the ways local communities are using opioid settlement funds. Survivors of the overdose crisis and families who’ve lost loved ones to it are raising alarms about what some perceive as wasteful spending.
-
GOP Cuts Will Cripple Medicaid Enrollment, Warns CEO of Largest Public Health Plan
Martha Santana-Chin, a daughter of Mexican immigrants, last year took the helm of L.A. Care, the nation’s largest publicly operated health plan. She warns that looming federal cuts will push up to 650,000 people off L.A. Care’s Medicaid rolls by the end of 2028.
-
Vaccines Are Helping Older People More Than We Knew
Many shots seem to have “off-target” benefits, such as lowering the risk of dementia, studies have found.
By Paula Span -
RFK Jr.’s MAHA Movement Has Picked Up Steam in Statehouses. Here’s What To Expect in 2026.
“Make America Healthy Again” policies driven by HHS Secretary Robert F. Kennedy Jr. have made major strides in state legislatures, with food additives among the most common targets. The trend is expected to continue this year.
-
Vaccines Jettisoned by CDC Safeguarded Millions From Disease
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
By Arthur Allen and Jackie Fortiér -
Thrift Store. Clinic. Roller Rink. Center Becomes ‘Radical’ Lifeline Amid Homelessness, Drug Crises.
Located in the Lower 9th Ward, this abandoned building has become a community sanctuary and resource.
-
In Lodge Grass, Montana, a Crow Community Works To Rebuild From Meth’s Destruction
Meth is a problem most everywhere, but particularly in Indian Country. On the Crow Indian Reservation in Montana, new buildings serve as symbols of a town trying to rebuild after being devastated by addiction.
-
Inside the Battle for the Future of Addiction Medicine
The experiences of one doctor in Louisiana reveal the tensions around trying to get people to engage in addiction treatment, even if they’re not ready to stop using drugs.
-
The CDC Just Sidelined These Childhood Vaccines. Here’s What They Prevent.
The CDC is recommending fewer childhood vaccines, although the ones it has jettisoned from the recommended schedule have successfully battled serious illness for years. Experts warn that if vaccine uptake falls, millions could be hospitalized — or worse — as a result of preventable diseases.
By Arthur Allen and Jackie Fortiér -
To Knock Down Health-System Hurdles Between You and HIV Prevention, Try These 6 Things
It’s been more than 10 years since the FDA first approved an HIV prevention drug. Today, people who could benefit from preexposure prophylaxis often struggle to access the lifesaving medicine or run into doctors without the education or empathy to offer affirming care. And those lapses can produce billing headaches.
By Zach Dyer -
Inside the FDA’s Vaccine Uproar
An internal email claiming covid vaccines killed children triggered a formal response from a dozen past FDA commissioners. The email, sent by the head of the Center for Biologics Evaluation and Research, outlines a framework that could have significant impact on the nation’s vaccine policies.
-
Guns Marketed for Personal Safety Fuel Public Health Crisis in Black Communities
During the covid pandemic, gun marketers told many Americans they needed firearms to defend against criminals and protesters. Then firearm deaths mounted rapidly in racially segregated and low-income neighborhoods, according to federal data.
By Fred Clasen-Kelly and Daniel Chang -
Vaccine Panel’s Hepatitis B Vote Signals Further Turbulence for Immunization Policy, Public Trust
Clinicians and epidemiologists warn the decision to no longer recommend the birth dose of the hepatitis B vaccine could unravel decades of progress and expose newborns to a deadly, preventable disease.